Pluri Biotech Competitors and Similar CompaniesClear all

Pluri Biotech's competitors and similar companies include Laronde, Bolt Biotherapeutics, Aurion Biotech and Eigen Therapeutics.

	Pluri Biotech Pluri Biotech (פלורי ביוטק בע"מ, formerly Pluristem Therapeutics) is a clinical-stage biotherapy company developing cell therapies.	Laronde Laronde is a biotech company that develops a platform based on an engineered form of RNA (eRNA), which can be programmed to express therapeutic proteins inside the body.	Bolt Biotherapeutics Bolt Biotherapeutics is a biotechnology company developing immunotherapeutics for multiple types of cancer.	Aurion Biotech Aurion Biotech is a clinical stage biotech company that develops a platform of therapies to cure blindness.	Eigen Therapeutics Eigen Therapeutics is a biotechnology company that develops therapeutics for cancer.
Founding Date	Founding Date 2003	Founding Date 2017	Founding Date 2015	Founding Date 2021	Founding Date 2021
Type	Type Public	Type Private	Type Public	Type Private	Type Private
Tags	Tags Technology biotech platform therapy	Tags Healthcare Technology biotech platform therapy	Tags Technology biotech oncology platform therapy	Tags Technology biotech healthtech platform therapy	Tags Technology biotech platform therapy
Locations	Locations Haifa, IL HQ Potsdam, DE	Locations HQ	Locations Redwood City, US HQ	Locations Seattle, US HQ	Locations Redwood City, US HQ
Employees	Employees 106	Employees 435% increase	Employees 5248% decrease	Employees 901% decrease	Employees 10
Valuation ($)	Valuation ($) 25.2 m	Valuation ($) N/A	Valuation ($) 25.6 m	Valuation ($) N/A	Valuation ($) N/A
Financial
Revenue (est.)	Revenue (est.) $1.3m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) $7.7m (FY, 2025)	Revenue (est.) N/A	Revenue (est.) N/A
Net income	Net income ($23.3m) (FY, 2025)	Net income N/A	Net income ($33.4m) (FY, 2025)	Net income N/A	Net income N/A
Funding
Latest funding round	Latest funding round N/A	Latest funding round $ 440m (over 4 years ago)	Latest funding round N/A	Latest funding round $ 120m (about 4 years ago)	Latest funding round $ 7m (over 3 years ago)
Total funding raised	Total funding raised $ 78.4m	Total funding raised $ 490m	Total funding raised $ 177.5m	Total funding raised $ 120m	Total funding raised $ 7m

For sources of this data, please see the company profile

View Company Profiles

Laronde

Employees

43↑ 5% increase

Laronde is a biotech company that develops a platform based on an engineered form of RNA (eRNA), which can be programmed to express therapeutic proteins inside the body.

View company

Bolt Biotherapeutics

Redwood City, US

Employees

52↓ 48% decrease

Bolt Biotherapeutics is a biotechnology company developing immunotherapeutics for multiple types of cancer.

View company

Aurion Biotech

Seattle, US

Employees

90↓ 1% decrease

Aurion Biotech is a clinical stage biotech company that develops a platform of therapies to cure blindness.